The frequencies of DRB1*01 were lower in the controls than in LADA patients after the third round, indicating an effect on the risk of developing LADA (χ2 = 12.181, p < 0.001). This evidence concerns the gene HLA-DRB1 and latent autoimmune diabetes in adults.